ArticleThe American journal of gastroenterology2018
Correction: ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
Article in The American journal of gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Effect of polyphenol compounds onBMJ open · 2023Pooled it
- Combination of vonoprazan and amoxicillin as the first-line Helicobacter pylori eradication therapy: a multicenter, prospective, randomized, parallel-controlled study.Clinical and experimental medicine · 2023Trial
- Proton Pump Inhibitors (PPIs)-An Evidence-Based Review of Indications, Efficacy, Harms, and Deprescribing.Medicina (Kaunas, Lithuania) · 2025Review
- Probiotics and prebiotics: new treatment strategies for oral potentially malignant disorders and gastrointestinal precancerous lesions.NPJ biofilms and microbiomes · 2025Review
- Enhanced fatty acid biosynthesis by Sigma28 in stringent responses contributes to multidrug resistance and biofilm formation inAntimicrobial agents and chemotherapy · 2024Article
- Comparison of metronidazoleJGH open : an open access journal of gastroenterology and hepatology · 2024Article
- Novel therapeutic regimens againstFrontiers in microbiology · 2024Review
- Prospective Study of Vonoprazan-Based First-Line Triple Therapy with Amoxicillin and Metronidazole for Clarithromycin-ResistantJournal of clinical medicine · 2023Article
- Evolution ofAntibiotics (Basel, Switzerland) · 2023Review
- Antimicrobial-Resistance Profile ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023Article
- Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication ofFrontiers in pharmacology · 2022Article
- Evaluation of the Effectiveness ofMedicina (Kaunas, Lithuania) · 2021Article
- Changes in the Seroprevalence ofMedicina (Kaunas, Lithuania) · 2021Article
- Is Only Clarithromycin Susceptibility Important for the Successful Eradication ofAntibiotics (Basel, Switzerland) · 2020Article
- Efficacy of tailored second-line therapy ofGut pathogens · 2020Article
Corrections and comments
- Erratum for
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since the publication of this manuscript it was realised that reference 14 was provided incorrectly. The correct reference is provided here.
Identifiers
29895984What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.